Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Biodelivery Sci Intl (BDSI)

Biodelivery Sci Intl (BDSI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 415,184
  • Shares Outstanding, K 100,165
  • Annual Sales, $ 111,390 K
  • Annual Income, $ -15,310 K
  • 60-Month Beta 0.75
  • Price/Sales 3.79
  • Price/Cash Flow 22.80
  • Price/Book 5.31

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate 0.04
  • Number of Estimates 4
  • High Estimate 0.06
  • Low Estimate 0.02
  • Prior Year 0.06
  • Growth Rate Est. (year over year) -33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.09 +3.79%
on 07/10/20
4.83 -12.11%
on 06/16/20
-0.24 (-5.25%)
since 06/12/20
3-Month
4.02 +5.60%
on 04/16/20
5.39 -21.24%
on 05/08/20
-0.02 (-0.35%)
since 04/14/20
52-Week
2.85 +48.95%
on 03/23/20
7.21 -41.12%
on 12/26/19
+0.17 (+4.30%)
since 07/12/19

Most Recent Stories

More News
Why Is BioDelivery (BDSI) Down 0.4% Since Last Earnings Report?

BioDelivery (BDSI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

BDSI : 4.23 (+1.93%)
BioDelivery Sciences to Present at Two Upcoming Investor Conferences

BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that...

BDSI : 4.23 (+1.93%)
The global opioids drugs market is anticipated to grow at a CAGR of 2.48% over the forecast period of 2019-2028

, /PRNewswire/ -- The global opioids drugs market is anticipated to grow at a CAGR of 2.48% over the forecast period of 2019-2028. The major factors augmenting the global market growth are the growing...

ACUR : 0.3025 (-0.17%)
AGN : 193.02 (+0.02%)
BDSI : 4.23 (+1.93%)
COLL : 16.38 (-0.12%)
EGLT : 0.0315 (-63.37%)
HKMPF : 26.2000 (-0.95%)
LCI : 4.91 (-6.30%)
PFE : 35.02 (-0.54%)
TEVA : 11.55 (-0.17%)
BioDelivery Sciences Appoints Jeff Bailey Interim CEO

BioDelivery Sciences International, Inc (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that...

BDSI : 4.23 (+1.93%)
BioDelivery (BDSI) Beats on Q1 Earnings, Withdraws Guidance

BioDelivery's (BDSI) strong Belubca sales drive the topline. Symproic further boosts revenues. Stock up.

ENDP : 3.31 (-2.65%)
IMMU : 40.11 (+0.35%)
BDSI : 4.23 (+1.93%)
SGEN : 171.16 (+1.53%)
BioDelivery Sciences International (BDSI) Beats Q1 Earnings and Revenue Estimates

BioDelivery (BDSI) delivered earnings and revenue surprises of 400.00% and 15.33%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

BDSI : 4.23 (+1.93%)
BioDelivery Sciences Reports Strong Q1 2020 Results

First Quarter Total Company Net Sales Increased 94% versus Prior Year to $38.3 Million

BDSI : 4.23 (+1.93%)
9 Meters Biopharma, a Rare, Orphan and Unmet Needs GI-Focused Company, is Created with the Transformative Merger Between Innovate Biopharmaceuticals and RDD Pharma

Completes concurrent financing of ~$22 million led by Orbimed Advisors, LLC

INNT : 0.5600 (-20.23%)
BDSI : 4.23 (+1.93%)
BioDelivery Sciences International (BDSI) Earnings Expected to Grow: Should You Buy?

BioDelivery (BDSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BDSI : 4.23 (+1.93%)
BioDelivery Sciences to Report First Quarter 2020 Financial Results on May 7, 2020

BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that...

BDSI : 4.23 (+1.93%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade BDSI with:

Business Summary

BioDelivery Sciences International is a development-stage biotechnology company that is developing and seeking to commercialize a drug delivery technology designed for a potentially broad base of pharmaceuticals, vaccines and over-the-counter drugs. In general, a drug delivery technology refers to any...

See More

Key Turning Points

2nd Resistance Point 4.43
1st Resistance Point 4.29
Last Price 4.23
1st Support Level 4.07
2nd Support Level 3.99

See More

52-Week High 7.21
Fibonacci 61.8% 5.54
Fibonacci 50% 5.03
Fibonacci 38.2% 4.52
Last Price 4.23
52-Week Low 2.85

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar